Second line salvage systemic therapy for advanced penile cancer

Volume: 40, Issue: 6, Pages: 229 - 234
Published: Jun 1, 2022
Abstract
Most patients with advanced penile cancer will have relapsed disease after cisplatin-based combination chemotherapy. Unfortunately, these patients have dismal outcomes with salvage chemotherapy, surgery, or radiation. In this review we will discuss the available chemotherapy and targeted therapies for salvage second line systemic treatment for patients with penile cancer. We will also summarize the ongoing interventional clinical trials using...
Paper Details
Title
Second line salvage systemic therapy for advanced penile cancer
Published Date
Jun 1, 2022
Volume
40
Issue
6
Pages
229 - 234
Citation AnalysisPro
  • Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
  • Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.